Compare WLDS & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WLDS | VVOS |
|---|---|---|
| Founded | 2014 | 2016 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Communications Equipment | Medical Specialities |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.7M | 19.4M |
| IPO Year | 2022 | 2020 |
| Metric | WLDS | VVOS |
|---|---|---|
| Price | $1.45 | $2.05 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.25 |
| AVG Volume (30 Days) | ★ 239.4K | 139.4K |
| Earning Date | 12-10-2025 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $422,000.00 | ★ $17,317,000.00 |
| Revenue This Year | N/A | $17.96 |
| Revenue Next Year | N/A | $55.64 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 18.76 |
| 52 Week Low | $1.00 | $1.93 |
| 52 Week High | $11.40 | $7.95 |
| Indicator | WLDS | VVOS |
|---|---|---|
| Relative Strength Index (RSI) | 31.38 | 38.28 |
| Support Level | $1.83 | $1.93 |
| Resistance Level | $1.60 | $2.28 |
| Average True Range (ATR) | 0.12 | 0.12 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 5.38 | 26.00 |
Wearable Devices Ltd develops and sells human-machine interface solutions for the smart wearables industry. These digital devices include consumer electronics, smart watches, smartphones, AR glasses, VR headsets, televisions, PCs, laptop computers, drones, robots, etc. The company has completed the transition phase from research and development to commercialization of technology into B2B and B2C products. Its products include Mudra Inspire, a band for the Apple Watch that allows touchless operation and control of Apple ecosystem devices such as iPhone, Mac computer, Apple TV, and iPad, inter alia.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.